NIOX Group (LON:NIOX) Posts Quarterly Earnings Results

NIOX Group (LON:NIOX – Get Free Report) issued its earnings results on Wednesday. The company reported GBX 1.41 EPS for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Trading Up 1.2%

NIOX Group stock traded up GBX 0.80 during trading hours on Friday, reaching GBX 66.80. The stock had a trading volume of 175,685 shares, compared to its average volume of 796,137. The stock has a market cap of £281.14 million, a PE ratio of 40.73 and a beta of 0.92. NIOX Group has a 52 week low of GBX 53.84 and a 52 week high of GBX 76. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94. The company has a fifty day simple moving average of GBX 65.81 and a 200-day simple moving average of GBX 61.71.

About NIOX Group

(Get Free Report)

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.

See Also

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.